Thomas E. Witzig
Author
Alternate names T. Witzig, T. E. Witzig, Thomas E. Witzig, Thomas Elmer Witzig, Thomas Witzig +1 more
Institution Mayo Clinic
Past institutions Mayo Clinic in Arizona, Mayo Clinic, WinnMed, Mayo Clinic in Florida, University of Minnesota Rochester +5 more
ORCID: Yes
H-index: 127
I10-index: 533
Works count: 1,255
Citations count: 58,570
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
2017 · Sattva S. Neelapu, Frederick L. Locke, et al. · New England Journal of Medicine
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 · Robert A. Kyle, Morie A. Gertz, et al. · Mayo Clinic Proceedings
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
2002 · Thomas E. Witzig, Leo I. Gordon, et al. · Journal of Clinical Oncology